http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019509279-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0075
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0075
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-864
filingDate 2017-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2019509279-A
titleOfInvention Use of DREADD for neuronal modulation in the treatment of neuronal diseases
abstract Inhibitory and / or hyperactive DREADD is used to modulate neuronal activity in the inner pallidum (GPi), anterior motor thalamus and / or outer pallidum (GPe) and / or subthalamic nucleus (STN) This provides a method for treating a patient suffering from a neuronal hypoactivity disorder or a neuronal hyperactivity disorder.
priorityDate 2016-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017049252-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4624
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29190
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491223
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID556499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574814
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID461776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3763
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414856086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415972366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135445691
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281385
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5173

Total number of triples: 50.